Cholesterol and triglycerides in antipsychotic-naive patients with nonaffective psychosis

Psychiatry Research

Volumn 178, Issue 3, 2010, Pages 559-561

  Kirkpatrick, Brian ^a   Garcia Rizo, Clemente ^b   Tang, Kun ^a   Fernandez Egea, Emilio ^c,d   Bernardo, Miguel ^b,e,f  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^f CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Cholesterol; Lipids; Metabolism; Schizophrenia; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; BLOOD; CASE CONTROL STUDY; REGRESSION ANALYSIS; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; TRIGLYCERIDES; YOUNG ADULT;

EID: 77955176909     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.06.001     Document Type: Article

References (15)

1. Braun L.T. Lipid disorders in type 2 diabetes. The Nursing Clinics of North America 2001, 36:291-302.
2. Fernandez-Egea E., Bernardo M., Donner T., Conget I., Parellada E., Justicia A., Esmatjes E., Garcia-Rizo C., Kirkpatrick B. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. British Journal of Psychiatry 2009, 194:434-438.
3. Fernandez-Egea E., Bernardo M., Heaphy C.M., Griffith J.K., Parellada E., Esmatjes E., Conget I., Nguyen L., George V., Stöppler H., Kirkpatrick B. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophrenia Bulletin 2009, 35:437-442.
4. Hollingshead A.B., Redlich F.C. Social Class and Mental Illness 1958, John Wiley & Sons, New York.
5. Howard B.V. Insulin resistance and lipid metabolism. The American Journal of Cardiology 1999, 84:28J-32J.
6. Meyer J.M., Koro C.E. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophrenia Research 2004, 70:1-17.
7. Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. The Journal of Clinical Psychiatry 2007, 68(Suppl 4):8-13.
8. Olfson M., Marcus S.C., Corey-Lisle P., Tuomari A.V., Hines P., L'Italien G.J. Hyperlipidemia following treatment with antipsychotic medications. The American Journal of Psychiatry 2006, 163:1821-1825.
9. Rosenberg S.D., Drake R.E., Wolford G.L., Mueser K.T., Oxman T.E., Vidaver R.M., Carrieri K.L., Luckoor R. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. The American Journal of Psychiatry 1998, 155:232-238.
10. Ryan M.C.M., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. The American Journal of Psychiatry 2003, 160:284-289.
11. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Archives of General Psychiatry 2007, 64:1123-1131.
12. Suvisaari J., Perälä J., Saarni S.I., Härkänen T., Pirkola S., Joukamaa M., Koskinen S., Lönnqvist J., Reunanen A. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:129-136.
13. Tschoner A., Engl J., Laimer M., Kaser S., Rettenbacher M., Fleischhacker W.W., Patsch J.R., Ebenbichler C.F. Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice 2007, 61:1356-1370.
14. Verma S.K., Subramaniam M., Liew A., Poon L.Y. Metabolic risk factors in drug-naive patients with first-episode psychosis. The Journal of Clinical Psychiatry 2009, 70:997-1000.
15. Wahlbeck K., Forsén T., Osmond C., Barker D.J., Eriksson J.G. Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood. Archives of General Psychiatry 2001, 58:48-52.